OGN INVESTIGATION ALERT: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm

Group 1 - The law firm Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Organon & Co., focusing on whether false or misleading statements were made by the company and its executives [1][2] - Organon announced a significant dividend cut of approximately 90% on May 1, 2025, which led to a stock price decline of more than 28% [3] Group 2 - Organon is identified as a global healthcare company primarily focused on improving women's health [2] - Robbins Geller is recognized as one of the leading law firms in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [4]